Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.426% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) Cc1ccc(-c2ccc(SCC(=O)NC3CCCC3)nn2)cc1
b) Cc1cc(/C=C2/C(=O)NC(=O)N(c3ccccc3)C2=O)c(C)n1-c1ccc(F)cc1
c) CCOC(=O)C1=C(CC)Nc2ccccc2N=C1NC(=O)c1cccc(S(=O)(=O)N2CCOCC2)c1
Answer: a. Cc1ccc(-c2ccc(SCC(=O)NC3CCCC3)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2ccc(SCC(=O)NC3CCCC3)nn2)cc1
Cc1ccc(-c2ccc(SCC(=O)NC3CCCC3)nn2)cc1
N-cyclopentyl-2-[6-(4-methylphenyl)pyridazin-3-yl]sulfanylacetamide